NCT03822026

Brief Summary

Elevated intracranial pressure is a dangerous and potentially fatal complication after traumatic brain injury. Hyperventilation is a medical intervention to reduce elevated intracranial pressure by inducing cerebral vasoconstriction, which might be associated to cerebral ischemia and hypoxia. The main hypothesis is that a moderate degree of hyperventilation is sufficient to reduce the intracranial pressure without inducing cerebral ischemia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2014

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 2, 2017

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

January 22, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 30, 2019

Completed
Last Updated

January 30, 2019

Status Verified

January 1, 2019

Enrollment Period

3 years

First QC Date

January 22, 2019

Last Update Submit

January 29, 2019

Conditions

Keywords

intracranial pressurecerebral metabolismcerebral oxygenation

Outcome Measures

Primary Outcomes (1)

  • intracranial pressure

    Change of intracranial pressure during moderate hyperventilation

    10, 20, 50, 60 minutes after begin of the hyperventilation test

Secondary Outcomes (3)

  • cerebral flow velocity in the middle cerebral artery

    20, 50, 60 minutes after begin of the hyperventilation test

  • brain tissue oxygenation (PbrO2)

    10, 20, 50, 60 minutes after begin of the hyperventilation test

  • cerebral Lactate/ Pyruvate ratio

    1 hour before initiation of the hyperventilation test, and 1 and 2 hours after begin of the hyperventilation test

Study Arms (1)

patients with severe TBI

OTHER

Patients with severe TBI enrolled in the study undergo an hyperventilation test, in which the alveolar ventilation is increased by a stepwise increase in tidal volumes and respiratory rate until a reduction of etCO2 of 0.7 kPa is achieved.

Other: Hyperventilation test

Interventions

Increase of the alveolar ventilation by a stepwise increase in tidal volumes and respiratory rate until a reduction of end-tidal CO2 of 0.7 kPa is achieved

patients with severe TBI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • nonpenetrating traumatic brain injury
  • Glasgow coma scale \<9 at presentation
  • Intracranial pressure monitoring
  • brain tissue oxygen tension monitoring and/or microdialysis monitoring
  • invasive mechanical ventilation with FIO2 \<60% and PEEP \<15 mbar

You may not qualify if:

  • decompressive craniectomy
  • pregnancy
  • pre-existing neurological disease
  • previous traumatic brain injury
  • acute cardiovascular disease
  • severe respiratory failure
  • acute on chronic liver disease
  • sepsis
  • failure to obtain satisfactory bilateral TCCD signals
  • persisting hypovolemia or hemodynamic instability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Zurich

Zurich, 8006, Switzerland

Location

Related Publications (2)

  • Klinzing S, Stretti F, Pagnamenta A, Bechir M, Brandi G. Transcranial color-coded duplex sonography assessment of cerebrovascular reactivity to carbon dioxide: an interventional study. BMC Neurol. 2021 Aug 7;21(1):305. doi: 10.1186/s12883-021-02310-9.

  • Brandi G, Stocchetti N, Pagnamenta A, Stretti F, Steiger P, Klinzing S. Cerebral metabolism is not affected by moderate hyperventilation in patients with traumatic brain injury. Crit Care. 2019 Feb 13;23(1):45. doi: 10.1186/s13054-018-2304-6.

MeSH Terms

Conditions

Hyperventilation

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Peter Steiger, MD

    University of Zurich

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: several parameters are collected at different time points: at baseline conditions, during moderate hyperventilation, and after return to baseline
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2019

First Posted

January 30, 2019

Study Start

May 20, 2014

Primary Completion

May 2, 2017

Study Completion

May 2, 2017

Last Updated

January 30, 2019

Record last verified: 2019-01

Locations